Your browser is no longer supported. Please, upgrade your browser.
Settings
OCX OncoCyte Corporation daily Stock Chart
OCX [NYSE]
OncoCyte Corporation
Index- P/E- EPS (ttm)-0.38 Insider Own23.90% Shs Outstand55.78M Perf Week-1.79%
Market Cap122.16M Forward P/E- EPS next Y-0.39 Insider Trans- Shs Float31.90M Perf Month-42.06%
Income-15.80M PEG- EPS next Q-0.09 Inst Own31.20% Short Float2.96% Perf Quarter-50.00%
Sales- P/S- EPS this Y35.10% Inst Trans0.27% Short Ratio2.65 Perf Half Y36.87%
Book/sh0.82 P/B2.67 EPS next Y-8.30% ROA-83.00% Target Price7.15 Perf Year-32.62%
Cash/sh0.72 P/C3.06 EPS next 5Y- ROE-113.20% 52W Range1.16 - 6.92 Perf YTD58.70%
Dividend- P/FCF- EPS past 5Y10.80% ROI- 52W High-69.94% Beta5.00
Dividend %- Quick Ratio12.80 Sales past 5Y- Gross Margin- 52W Low78.54% ATR0.35
Employees12 Current Ratio12.80 Sales Q/Q- Oper. Margin- RSI (14)34.15 Volatility9.55% 12.49%
OptionableYes Debt/Eq0.04 EPS Q/Q30.60% Profit Margin- Rel Volume0.47 Prev Close2.19
ShortableYes LT Debt/Eq0.01 EarningsAug 13 AMC Payout- Avg Volume355.25K Price2.08
Recom1.80 SMA20-26.02% SMA50-43.93% SMA200-30.75% Volume167,189 Change-5.02%
Feb-13-19Initiated Piper Jaffray Overweight $6
Jan-29-19Upgrade Janney Neutral → Buy
Dec-19-18Resumed Lake Street Buy
Jul-11-19 03:30PM  SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of OncoCyte Corporation - OCX ACCESSWIRE -6.85%
11:28AM  Is OncoCyte Corporation (NYSEMKT:OCX) Trading At A 47% Discount? Simply Wall St.
Jul-09-19 05:08PM  SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of OncoCyte Corporation - OCX GlobeNewswire -8.97%
Jul-07-19 05:33PM  Insiders Roundup: OncoCyte, BioSciences GuruFocus.com
Jul-02-19 04:22PM  SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of OncoCyte Corporation - OCX GlobeNewswire -21.12%
02:23PM  Bronstein, Gewirtz & Grossman, LLC Announces Investigation of OncoCyte Corporation (OCX) ACCESSWIRE
Jun-26-19 09:05AM  OncoCyte Provides Mid-Year Update GlobeNewswire -36.84%
Jun-25-19 08:37AM  Penny Stocks to Buy Using Technical Analysis for June 2019 Investopedia
Jun-11-19 04:35PM  The Companies Set To Join The Russell Index July 1 Benzinga -10.71%
08:00AM  OncoCyte to be Added to the Russell 2000®, 3000® and Microcap Indexes GlobeNewswire
Jun-06-19 06:30AM  OncoCyte Announces Chief Executive Officer Transition GlobeNewswire -8.35%
May-29-19 04:05PM  OncoCyte Announces Participation at the 2019 BIO International Convention GlobeNewswire
07:00AM  OncoCyte Strengthens Senior Management Team With Two New Hires GlobeNewswire
May-21-19 03:15PM  OncoCyte Presents Positive Results from R&D Validation Study of DetermaVu at the American Thoracic Society 2019 International Conference GlobeNewswire
May-20-19 10:20AM  OncoCyte (OCX) Catches Eye: Stock Jumps 7.3% Zacks -5.32%
May-14-19 11:44PM  OncoCyte Corporation (OCX) Q1 2019 Earnings Call Transcript Motley Fool
04:18PM  OncoCyte: 1Q Earnings Snapshot Associated Press
04:05PM  OncoCyte Provides Corporate Update and Reports First Quarter 2019 Financial Results GlobeNewswire
02:30PM  OncoCyte Corp. to Host Earnings Call ACCESSWIRE
May-08-19 04:01PM  OncoCyte to Report First Quarter 2019 Financial Results on Tuesday, May 14 GlobeNewswire
Apr-25-19 08:00AM  OncoCyte Announces Successful Completion of Analytical Validation Study and Commencement of CLIA Validation Study GlobeNewswire
Apr-24-19 12:06PM  The OncoCyte (NYSEMKT:OCX) Share Price Has Gained 106%, So Why Not Pay It Some Attention? Simply Wall St.
Apr-01-19 04:20PM  OncoCyte: 4Q Earnings Snapshot Associated Press +7.59%
04:06PM  OncoCyte Provides Corporate Update and Reports Fourth Quarter and Full Year 2018 Financial Results GlobeNewswire
04:05PM  OncoCyte to Present Late Breaking Abstract at the American Thoracic Society 2019 International Conference GlobeNewswire
02:30PM  OncoCyte Corp. to Host Earnings Call ACCESSWIRE
Mar-25-19 04:05PM  OncoCyte to Report Fourth Quarter and Full-Year 2018 Financial Results on Monday, April 1, 2019 GlobeNewswire
Mar-20-19 11:05AM  Teladoc to Acquire MedecinDirect, Expand Overseas Business Zacks
Mar-06-19 04:15PM  OncoCyte Corporation to Present at Cowen and Company 39th Annual Health Care Conference in Boston GlobeNewswire
Mar-04-19 04:05PM  OncoCyte Announces Initiation of Analytical Validation Study GlobeNewswire
Feb-14-19 08:00AM  BioTime Provides Business Update Including Information on AgeX, OncoCyte and Asterias GlobeNewswire
Feb-12-19 04:05PM  OncoCyte Announces Closing of Public Offering of Common Stock GlobeNewswire
Feb-08-19 09:00AM  OncoCyte Announces Pricing of Public Offering of Common Stock GlobeNewswire -6.98%
Feb-07-19 04:05PM  OncoCyte Announces Proposed Public Offering of Common Stock GlobeNewswire
Jan-31-19 11:05AM  OncoCyte soars after promising results from its cancer detection tests Yahoo Finance Video -9.42%
Jan-30-19 12:15PM  Here's Why OncoCyte Is Giving Back Some Gains Today Motley Fool -12.01%
08:30AM  Has OncoCyte Changed How We Will Diagnose Cancer in the Near Future? ACCESSWIRE
08:00AM  Today's Research Reports on Trending Tickers: Amgen and OncoCyte ACCESSWIRE
Jan-29-19 02:30PM  These 4 Healthcare Stocks Healthy With Potential Opportunities ACCESSWIRE +224.73%
02:14PM  OncoCyte upgraded to buy at Janney on high hopes for lung cancer biopsy test MarketWatch
10:25AM  Tiny Health Stock Triples After Lung Cancer Test Wins Wall Street Praise Bloomberg
08:47AM  OncoCyte's stock doubles on heavy volume after positive results of cancer detection test MarketWatch
07:14AM  OncoCyte Announces Successful Results of DetermaVu R&D Validation Study GlobeNewswire
Jan-28-19 04:30PM  OncoCyte Schedules Announcement and Conference Call to Discuss Results from Key R&D Validation Study of DetermaVu GlobeNewswire -5.21%
Jan-03-19 08:00AM  OncoCyte Announces Transition to Ion Torrent Next-Generation Sequencing Platform GlobeNewswire +5.44%
Dec-20-18 04:18PM  OncoCyte Provides Progress Update on Ongoing Studies GlobeNewswire
Nov-30-18 10:38AM  OncoCyte Corporation to Present at the LD Micro 11th Annual Main Event Investor Conference GlobeNewswire
Nov-26-18 07:50AM  Report: Developing Opportunities within Summit Midstream Partners, LP, Empire State Realty Trust, Expeditors International of Washington, Ellington Residential Mortgage REIT, OncoCyte, and Sachem Capital Future Expectations, Projections Moving into 2018 GlobeNewswire -7.78%
Nov-19-18 04:05PM  OncoCyte Corporation to Present at the Piper Jaffray 30th Annual Health Care Conference GlobeNewswire
Nov-13-18 06:08PM  OncoCyte: 3Q Earnings Snapshot Associated Press
04:05PM  OncoCyte Reports Third Quarter 2018 Financial Results and Progress in DetermaVu Development GlobeNewswire
Nov-06-18 09:00AM  Oncocyte to Report Third Quarter 2018 Financial Results on November 13, 2018 GlobeNewswire
Oct-29-18 04:05PM  OncoCyte Completes Successful Transition to New Diagnostic Testing Platform and Initiates DetermaVu Development Studies GlobeNewswire
Oct-17-18 08:00AM  OncoCyte Corporation to Present at the BIO CEO Investor Forum GlobeNewswire
Aug-14-18 05:50PM  OncoCyte: 2Q Earnings Snapshot Associated Press +9.62%
04:10PM  OncoCyte Reports Second Quarter 2018 Financial Results and Positive Corporate Developments GlobeNewswire
Aug-13-18 02:43PM  Who Are The Major Shareholders In OncoCyte Corporation (NYSEMKT:OCX)? Simply Wall St.
Aug-09-18 04:10PM  Seasoned Healthcare Executive Albert P. Parker Appointed Chief Operating Officer of OncoCyte GlobeNewswire
Jul-30-18 07:00AM  OncoCyte to Report Second Quarter 2018 Financial Results on August 14, 2018 GlobeNewswire
Jul-27-18 09:00AM  OncoCyte Announces At-Market $3.59 Million Offering of Common Stock and Warrants GlobeNewswire -5.26%
Jul-11-18 08:36AM  OncoCyte (OCX) in Focus: Stock Moves 13.1% Higher Zacks -8.70%
08:10AM  Today's Research Reports on Stocks to Watch: Loxo Oncology and OnoCyte ACCESSWIRE
Jul-10-18 05:46PM  OncoCyte (OCX) Stock Skyrockets on Lung Cancer Test Study Results InvestorPlace +13.11%
09:34AM  OncoCyte Surges on 'Encouraging' Results for Diagnostic Test for Cancer TheStreet.com
08:11AM  Benzinga's Daily Biotech Pulse: Acceleron On Fast Lane, OncoCyte's Accurate Diagnosis, Inspire Medical Gets Aetna Coverage Benzinga
Jul-09-18 04:10PM  OncoCyte Reports Encouraging New Study Results for Lung Cancer Blood Test GlobeNewswire
Jul-02-18 05:02AM  OncoCyte Sees Hammer Chart Pattern: Time to Buy? Zacks
Jun-13-18 07:53AM  Envision Healthcare to Go Private With Acquisition by KKR Zacks
Jun-05-18 07:48AM  Teladoc (TDOC) Buys Advance Medical to Boost Global Presence Zacks +15.09%
May-31-18 06:40AM  Can The Uptrend Continue for OncoCyte (OCX)? Zacks +14.04%
May-16-18 02:49PM  Investing Focused in Canada, U.S. and Europe, Says Onex CEO Bloomberg Video
May-15-18 05:50PM  OncoCyte: 1Q Earnings Snapshot Associated Press
04:10PM  OncoCyte Reports First Quarter 2018 Financial Results GlobeNewswire
May-08-18 07:00AM  OncoCyte to Report First Quarter 2018 Financial Results on May 15, 2018 GlobeNewswire
Apr-03-18 07:00AM  Leading Molecular Diagnostics Executive Ronnie Andrews Appointed to OncoCytes Board of Directors GlobeNewswire
Apr-02-18 05:17PM  OncoCyte reports 4Q loss Associated Press +7.14%
04:12PM  OncoCyte Reports Fourth Quarter and Full Year 2017 Financial Results GlobeNewswire
04:10PM  OncoCyte Files Patents for 190 Newly Identified Novel Lung Cancer Biomarkers GlobeNewswire
07:00AM  OncoCyte Names Cavan Redmond Chairman of the Board of Directors GlobeNewswire
Mar-30-18 08:55PM  Does OncoCyte Corporations (NYSEMKT:OCX) CEO Pay Compare Well With Peers? Simply Wall St.
Mar-29-18 07:00AM  OncoCyte to Report Fourth Quarter and Full Year 2017 Financial Results on April 2, 2018 GlobeNewswire +61.54%
Mar-28-18 08:40PM  OncoCyte Announces the Closing of a $10 Million Private Placement of Common Stock GlobeNewswire
Mar-22-18 07:38PM  What You Must Know About OncoCyte Corporations (NYSEMKT:OCX) Market Risks Simply Wall St. -13.33%
Mar-14-18 05:10PM  OncoCyte Corporation (NYSEMKT:OCX) Is Expected To Breakeven Simply Wall St. +7.50%
OncoCyte Corporation engages in the development and commercialization of non-invasive blood-based diagnostic tests for the early detection of cancer. The company is developing DetermaVu, a non-invasive molecular lung cancer confirmatory diagnostic that is administered to patients as a blood test. It also develops diagnostic tests based on liquid biopsies for detecting breast cancer. The company was founded in 2009 and is based in Alameda, California.